430 related articles for article (PubMed ID: 29976229)
1. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.
Yang N; Mosher R; Seo S; Beebe D; Friedl A
Am J Pathol; 2011 Jan; 178(1):325-35. PubMed ID: 21224069
[TBL] [Abstract][Full Text] [Related]
3. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.
Maeda T; Alexander CM; Friedl A
Cancer Res; 2004 Jan; 64(2):612-21. PubMed ID: 14744776
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
Yang N; Friedl A
PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
[TBL] [Abstract][Full Text] [Related]
5. Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation.
Su G; Blaine SA; Qiao D; Friedl A
Cancer Res; 2008 Nov; 68(22):9558-65. PubMed ID: 19010933
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
Maeda T; Desouky J; Friedl A
Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 facilitates breast cancer metastasis to the brain.
Sayyad MR; Puchalapalli M; Vergara NG; Wangensteen SM; Moore M; Mu L; Edwards C; Anderson A; Kall S; Sullivan M; Dozmorov M; Singh J; Idowu MO; Koblinski JE
Breast Cancer Res Treat; 2019 Nov; 178(1):35-49. PubMed ID: 31327090
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.
Miše I; Vučić M
Anal Cell Pathol (Amst); 2018; 2018():9432375. PubMed ID: 30151336
[TBL] [Abstract][Full Text] [Related]
9. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
[TBL] [Abstract][Full Text] [Related]
10. Ionizing radiation-mediated premature senescence and paracrine interactions with cancer cells enhance the expression of syndecan 1 in human breast stromal fibroblasts: the role of TGF-β.
Liakou E; Mavrogonatou E; Pratsinis H; Rizou S; Evangelou K; Panagiotou PN; Karamanos NK; Gorgoulis VG; Kletsas D
Aging (Albany NY); 2016 Aug; 8(8):1650-69. PubMed ID: 27434331
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor α regulates the expression of syndecan-1 in human breast carcinoma cells.
Fleurot E; Goudin C; Hanoux V; Bonnamy PJ; Levallet J
Endocr Relat Cancer; 2019 Jun; 26(6):615-628. PubMed ID: 30978702
[TBL] [Abstract][Full Text] [Related]
14. Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation.
Su G; Blaine SA; Qiao D; Friedl A
J Biol Chem; 2007 May; 282(20):14906-15. PubMed ID: 17344212
[TBL] [Abstract][Full Text] [Related]
15. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 suppresses epithelial-mesenchymal transition and migration in human oral cancer cells.
Wang X; He J; Zhao X; Qi T; Zhang T; Kong C
Oncol Rep; 2018 Apr; 39(4):1835-1842. PubMed ID: 29484435
[TBL] [Abstract][Full Text] [Related]
18. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma.
Binder Gallimidi A; Nussbaum G; Hermano E; Weizman B; Meirovitz A; Vlodavsky I; Götte M; Elkin M
PLoS One; 2017; 12(3):e0174343. PubMed ID: 28350804
[TBL] [Abstract][Full Text] [Related]
20. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
